Digoxin and Ataxia aggravated - a phase IV clinical study of FDA data
Ataxia aggravated is found among people who take Digoxin, especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years.
The phase IV clinical study analyzes which people take Digoxin and have Ataxia aggravated. It is created by eHealthMe based on reports of 87,772 people who have side effects when taking Digoxin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
87,772 people reported to have side effects when taking Digoxin.
Among them, 167 people (0.19%) have Ataxia aggravated.
What is Digoxin?
Digoxin has active ingredients of digoxin. It is often used in atrial fibrillation/flutter. eHealthMe is studying from 86,698 Digoxin users for its effectiveness, alternative drugs and more.
What is Ataxia aggravated?
Ataxia aggravated (serious loss of full control of bodily movements) is found to be associated with 745 drugs and 308 conditions by eHealthMe.
Number of Digoxin and Ataxia aggravated reports submitted per year:
Time on Digoxin when people have Ataxia aggravated *:
Gender of people who have Ataxia aggravated when taking Digoxin*:
Age of people who have Ataxia aggravated when taking Digoxin *:
Common drugs people take besides Digoxin *:
Common side effects people have besides Ataxia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Digoxin and have Ataxia aggravated?Check whether Ataxia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Guru SR, Suresh A, Padmanabhan S, Reddy A, "A Rare Case of Digoxin Associated Gingival Overgrowth", Journal of clinical and diagnostic research: JCDR, 2017 Jan .
- Lai SW, Lin CL, Liao KF, "Digoxin use may increase the relative risk of acute pancreatitis: a population-based case–control study in Taiwan", International journal of cardiology, 2015 Feb .
How severe was Ataxia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of digoxin:
Alternative drugs to, pros and cons of Digoxin:
- Digoxin (86,698 reports)
Common Digoxin side effects:
Browse all side effects of Digoxin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Ataxia aggravated treatments and more:
- Ataxia aggravated (6 reports)
COVID vaccines that are related to Ataxia aggravated:
- Ataxia aggravated in Moderna COVID Vaccine
- Ataxia aggravated in Pfizer BioNTech Covid Vaccine
- Ataxia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Ataxia aggravated:
All the drugs that are associated with Ataxia aggravated:
- Ataxia aggravated (745 drugs)
Common conditions associated with Ataxia aggravated:
All the conditions that are associated with Ataxia aggravated:
- Ataxia aggravated (308 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on digoxin (the active ingredients of Digoxin) and Digoxin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cosopt and Stress Cardiomyopathy - 3 seconds ago
- Maprotiline Hydrochloride and Dehydration - 4 seconds ago
- Ultracet and Metastasis - 7 seconds ago
- Vagifem and Blood Pressure Fluctuation - 12 seconds ago
- Iressa and Visual Impairment - 14 seconds ago
- Vitamins and Limb Asymmetry - 59 seconds ago
- Mesalamine and Food Allergy - a minute ago
- Intron A and Zoloft drug interaction - a minute ago
- Vitamin E and Mobility Decreased - a minute ago
- Diabetes and Coma Acidotic - 2 minutes ago